LXS, LLC

Medtech

A catheter-based device for direct sampling of lymph and lymphocytes from the thoracic duct

Grants
$2.3M
5 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
5
4 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Transvascular access and aspiration of thoracic duct lymph using a novel ultrasound guided approach.$150,382
Federal grantDepartment of Health and Human Services · Phase I · Transvascular access and aspiration of thoracic duct lymph using a novel ultrasound guided approach.$150,382
Federal grantDepartment of Health and Human Services · Phase II · Transvascular access and aspiration of thoracic duct lymph using a novel ultrasound guided approach.$483,956
Federal grantDepartment of Health and Human Services · Phase II · Transvascular access and aspiration of thoracic duct lymph using a novel ultrasound guided approach.$1,012,365
Federal grantDepartment of Health and Human Services · Phase II · Transvascular access and aspiration of thoracic duct lymph using a novel ultrasound guided approach.$528,409
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1964CHARLES RIVER ANALYTICS, INC.——
1965NYTRICX INC——
1966MICROBIOCHIP DIAGNOSTICS LLC——
1967LXS, LLC——
1968PNEUMICO, LLC——
1969Q'Apel Medical, Inc.—$68M
1970ALSUS MEDICAL, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 4 granted of 5

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.